MORF Projected Dividend Yield
Morphic Holding Inc ( NASDAQ : MORF )Morphic is a biopharmaceutical company. Co. is applying its proprietary insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with various approved injectable blockbuster drugs for the treatment of chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Co. is developing its pipeline, including its main product candidate, MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease. Co. has also developed selective oral avß6-specific integrin inhibitors including MORF-720 and MORF-627. 20 YEAR PERFORMANCE RESULTS |
MORF Dividend History Detail MORF Dividend News MORF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |